Safe Biopharma Association
Safe Biopharma Association sees declining revenue over eight years but maintains positive net assets with no reported officer compensation.
EIN: 203107081 · Ormond Beach, FL · Updated: 2026-03-28
Is Safe Biopharma Association Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Safe Biopharma Association directs 75% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Safe Biopharma Association
Safe Biopharma Association (EIN: 203107081) is a nonprofit organization based in Ormond Beach, FL. The organization reported total revenue of $1.4M and total assets of $615K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Safe Biopharma Association's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Safe Biopharma Association is a mid-size nonprofit that has been operating for 21 years, with 8 years of IRS 990 filings on record (2010–2017). Revenue has grown at a compound annual rate of -11.2%.
Key Financial Metrics (2017)
From the most recent IRS 990 filing on record:
| Total Revenue | $1.4M |
| Total Expenses | $1.2M |
| Surplus / Deficit | +$145K |
| Total Assets | $615K |
| Total Liabilities | $439K |
| Net Assets | $177K |
| Operating Margin | 10.7% |
| Debt-to-Asset Ratio | 71.3% |
| Months of Reserves | 6.1 months |
Financial Health Grade: A
In 2017, Safe Biopharma Association reported a surplus of $145K with revenue exceeding expenses, holds 6.1 months of operating reserves (strong position), has a debt-to-asset ratio of 71.3% (high leverage).
Financial Trends
Over 8 years of filings (2010–2017), Safe Biopharma Association's revenue has declined at a compound annual growth rate (CAGR) of -11.2%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2017 | -8.7% | -14.1% | -37.3% |
| 2016 | -8.2% | -7.7% | -3.7% |
| 2015 | -3.2% | -7.2% | +28.0% |
| 2014 | -0.1% | -14.1% | +2.6% |
| 2013 | -16.6% | -10.6% | -45.7% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 2005 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Safe Biopharma Association with a Mission Score of 70 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 75%
- fundraising: 10%
According to IRS 990 filings, Safe Biopharma Association allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2017)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $145K, with revenue exceeding expenses.
- Debt-to-asset ratio: 71.3%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all eight available filings, indicating that its leadership is either entirely volunteer-based or compensated through non-officer roles, which is highly unusual for an organization with over $1 million in annual revenue.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Safe Biopharma Association's IRS 990 filings:
- Significant and consistent decline in revenue over eight years (from $3.1M to $1.3M)
- Lack of detailed spending breakdown (program, admin, fundraising) in provided data
- NTEE code is unknown, hindering mission clarity and peer comparison
Strengths
The following positive indicators were identified for Safe Biopharma Association:
- Consistent positive net assets (assets exceed liabilities) in recent filings
- No reported officer compensation across all available filings, indicating potential for high efficiency or volunteer leadership
- History of operating for at least eight years, demonstrating longevity
Frequently Asked Questions about Safe Biopharma Association
Is Safe Biopharma Association a legitimate charity?
Based on AI analysis of IRS 990 filings, Safe Biopharma Association (EIN: 203107081) some concerns. Mission Score: 70/100. 3 red flags identified, 3 strengths noted.
How does Safe Biopharma Association spend its money?
Safe Biopharma Association directs 75% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Safe Biopharma Association tax-deductible?
Safe Biopharma Association is registered as a tax-exempt nonprofit (EIN: 203107081). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Is Safe Biopharma Association a good charity?
Based on the available data, the organization shows financial stability with assets exceeding liabilities and a notable commitment to not compensating officers. However, without detailed program spending information and a clear NTEE code, a full assessment of its programmatic impact and efficiency is limited.
Why has Safe Biopharma Association's revenue declined significantly since 2010?
The filings show a consistent decline in revenue from $3,122,328 in 201012 to $1,354,858 in 201712. This trend could be due to various factors such as changes in funding sources, economic conditions, or shifts in organizational strategy, which would require further inquiry beyond the provided data.
How does Safe Biopharma Association manage to operate with 0% officer compensation?
The consistent reporting of 0% officer compensation suggests that the organization's leadership may be entirely volunteer-driven or that compensation is structured in a way that it is not reported under 'officer compensation' on the 990 form. This is a significant factor in its operational model.
Filing History
IRS 990 filing history for Safe Biopharma Association showing financial trends over 8 years of public records:
Over 8 years of IRS 990 filings (2010–2017), Safe Biopharma Association's revenue has declined by 56.6%, moving from $3.1M to $1.4M. Total assets decreased by 64.9% over the same period, from $1.8M to $615K. Total functional expenses fell by 56.3%, from $2.8M to $1.2M. In its most recent filing year (2017), Safe Biopharma Association reported a surplus of $145K, with revenue exceeding expenses. The organization holds $439K in liabilities against $615K in assets (debt-to-asset ratio: 71.3%), resulting in net assets of $177K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2017 | $1.4M | $1.2M | $615K | $439K | — | View 990 |
| 2016 | $1.5M | $1.4M | $981K | $949K | — | View 990 |
| 2015 | $1.6M | $1.5M | $1.0M | $1.1M | — | View 990 |
| 2014 | $1.7M | $1.6M | $796K | $930K | — | View 990 |
| 2013 | $1.7M | $1.9M | $776K | $934K | — | View 990 |
| 2012 | $2.0M | $2.1M | $1.4M | $1.3M | — | View 990 |
| 2011 | $2.4M | $2.4M | $1.4M | $1.2M | — | View 990 |
| 2010 | $3.1M | $2.8M | $1.8M | $1.5M | — | View 990 |
Year-by-Year Financial Summary
- 2017: Revenue of $1.4M, expenses of $1.2M, and assets of $615K (revenue -8.7% year-over-year).
- 2016: Revenue of $1.5M, expenses of $1.4M, and assets of $981K (revenue -8.2% year-over-year).
- 2015: Revenue of $1.6M, expenses of $1.5M, and assets of $1.0M (revenue -3.2% year-over-year).
- 2014: Revenue of $1.7M, expenses of $1.6M, and assets of $796K (revenue -0.1% year-over-year).
- 2013: Revenue of $1.7M, expenses of $1.9M, and assets of $776K (revenue -16.6% year-over-year).
- 2012: Revenue of $2.0M, expenses of $2.1M, and assets of $1.4M (revenue -16.4% year-over-year).
- 2011: Revenue of $2.4M, expenses of $2.4M, and assets of $1.4M (revenue -23.2% year-over-year).
- 2010: Revenue of $3.1M, expenses of $2.8M, and assets of $1.8M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Safe Biopharma Association:
Data Sources and Methodology
This transparency report for Safe Biopharma Association is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.